T0	Participants 136 156	third molar surgery.
T1	Participants 316 392	patients undergoing lower third molar surgical extraction with bone removal.
T2	Participants 393 401	Patients
T3	Participants 935 1061	There were 86 patients (31 in the single-dose group, 28 in the 5-day group and 27 in the placebo group) enrolled in the study.